Reuters logo
BRIEF-Stemcells jumps in premarket after spinal cord injury trial results
February 12, 2013 / 1:05 PM / in 5 years

BRIEF-Stemcells jumps in premarket after spinal cord injury trial results

NEW YORK, Feb 12 (Reuters) - StemCells Inc : * Jumps 24.6 percent to $2.05 in premarket after spinal cord injury trial results

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below